Possible association between eosinophilic fasciitis and subcutaneous heparin use

Journal of Rheumatology

Volumn 25, Issue 2, 1998, Pages 383-385

  Cantini, Fabrizio ^a,d   Salvarani, Carlo ^b   Olivieri, Ignazio ^c   Padula, Angela ^c   Senesi, Carla ^a   Bellandi, Francesco ^a   Truglia, Maria Caterina ^a   Niccoli, Laura ^a   Palchetti, Roberto ^a  

^a Ospedale di Prato   (Italy)

^b Unità Reumatologica Ospedale di Reggio Emilia   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d Unità Reumatologica Ospedale di Reggio Emilia ^*  (Italy)

Author keywords

Eosinophilic fasciitis; Subcutaneous heparin

Indexed keywords

HEPARIN CALCIUM; HYDROXYCHLOROQUINE; PREDNISONE; UROKINASE;

ADULT; AGED; ALLERGIC PNEUMONITIS; ARTICLE; CASE REPORT; EOSINOPHILIC FASCIITIS; FEMALE; HEPARINIZATION; HUMAN; HUMAN TISSUE; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031888225     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Shulman LE. Diffuse fasciitis with eosinophilia: a new syndrome? Trans Assoc Am Physicians 1975;88:70-86.
2. Michel CJ, Doyle JA, Ginsburg WW. Eosinophilic fasciitis - report of 15 cases. Mayo Clin Proc 1981;56:27-34.
3. Kaufman LD, Krupp LB. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia. Curr Opin Rheumatol 1995;7:560-7.
4. Lee P. Eosinophilic fasciitis: new associations and current perspective [editorial]. J Rheumatol 1981;8:6-8.
5. Buchanan RRC, Gordon DA, Muckle TJ, McKenna F, Kraag G. The eosinophilic fasciitis syndrome after phenytoin (dilantin) therapy. J Rheumatol 1980;7:733-6.
6. Seaman JM, Goble M, Madsen L, Steigerwald JC. Fasciitis and polyarthritis during antituberculous therapy. Arthritis Rheum 1985;28:1179-84.
7. Waller PA, Clauw D, Cupps T, Metcalf JS, Silver RM, LeRoy CE. Fasciitis (not scleroderma) following prolonged exposure to an organic solvent (trichloroethylene). J Rheumatol 1994;21:567-70.
8. Seibold JR, Rodnan GP, Medsger TA, Winkelstein A. Circulating immune complexes in eosinophilic fasciitis. Arthritis Rheum 1982;25:1180-5.
9. Janin A, Socie G, Devergie A, et al. Fasciitis in chronic graft-versus-host disease - a clinicopathologic study of 14 cases. Ann Intern Med 1994;120:993-8.
10. Doyle JA, Ginsburg WW. Eosinophilic fasciitis. Med Clin North Am 1989;73:1157-66.
11. Kumagai Y, Shiokawa Y, Medsger TA, Rodnan GP. Clinical spectrum of connective tissue disease after cosmetic surgery. Arthritis Rheum 1984;27:1-12.
12. Archer G. Eosinophilia induced by heparin-protamine complexes. Pathology 1973;5:219-27.
13. Hiltenbrand C, Didier A, Lantrade P, et al. Long-term administration of calcium-heparin in thromboembolism. Ann Med Interne (Paris) 1980;131:406-9.
14. Schey S. Hypersensitivity reactions to heparin and the use of new low molecular weight heparins. Eur J Haematol 1989;42:107.
15. Giustolisi R, Guglielmo P, Di Raimondo F, Cacciola E, Stagno F. Hypereosinophilia and subcutaneous heparin. Lancet 1993;342:1371.
16. Bircher AJ, Fluckiger R, Buchner SA. Eczematous infiltrated plaques to subcutaneous heparin: a type IV allergic reaction. Br J Dermatol 1990;123:507-14.
17. Rosengart JK, Kupferschmid JP, Ferrans VJ, Casscells W, Maciag T, Clark RE. Heparin-binding growth factor-I (endothelial cell growth factor) binds to endothelium in vivo. J Vasc Surg 1988;7:311-7.
18. Pineda-Lucena A, Jimenez MA, Lozano RM, Nieto JL, Rico M, Gimenez-Gallego G. Three dimensional structure of acid fibroblast growth factor in solution: effects of binding to a heparin functional analog. J Mol Biol 1996;264:162-78.
19. Vlodavsky I, Miao HQ, Medalion B, Danagher P, Ron D. Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev 1996;15:177-86.